Showing results (431-440 of 493) with videos related to
Sort By:
Pageof 50
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 10, 2006
D-aspartate regulates melanocortin formation and function: behavioral alterations in D-aspartate oxidase-deficient miceAlex S Huang, Anne Beigneux, Zachary M Weil, et al.Seminars in Oncology|February 1, 1997
Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinomaD Coeffic, A Benhammouda, E C Antoine, et al.Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
Abnormal spermatogenesis and reduced fertility in transition nuclear protein 1-deficient miceY E Yu, Y Zhang, E Unni, et al.Behavioural Brain Research|May 27, 2006
Behavioural alterations in male mice lacking the gene for D-aspartate oxidaseZachary M Weil, Alex S Huang, Anne Beigneux, et al.Bollettino Dell'Istituto Sieroterapico Milanese|July 31, 1978
Prognostic factors in chronic granulocytic leukemia. A study of 798 casesC Jacquillat, C Chastang, J Tanzer, et al.The Journal of Biological Chemistry|October 29, 2000
CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa BJ Bertin, Y Guo, L Wang, et al.Experimental Neurology|July 21, 2023
Exercise intensity and sex alter neurometabolic, transcriptional, and functional recovery following traumatic brain injuryBrishti A White, Julia T Ivey, Ruth Velazquez-Cruz, et al.American Journal of Clinical Oncology|June 1, 1984
The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II studyP C Amrein, R F Poulin, M Coleman, et al.Blood|January 1, 1980
Acute monoblastic leukemia: a clinical and biologic study of 74 casesG Tobelem, C Jacquillat, C Chastang, et al.Pageof 50